Correlation
The correlation between SNX and NVO is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
SNX vs. NVO
Compare and contrast key facts about TD SYNNEX Corporation (SNX) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNX or NVO.
Performance
SNX vs. NVO - Performance Comparison
Loading data...
Key characteristics
SNX:
-0.16
NVO:
-1.05
SNX:
0.01
NVO:
-1.51
SNX:
1.00
NVO:
0.81
SNX:
-0.15
NVO:
-0.76
SNX:
-0.39
NVO:
-1.34
SNX:
13.21%
NVO:
34.06%
SNX:
33.41%
NVO:
43.26%
SNX:
-67.27%
NVO:
-71.29%
SNX:
-15.77%
NVO:
-50.36%
Fundamentals
SNX:
$10.24B
NVO:
$303.58B
SNX:
$7.95
NVO:
$3.54
SNX:
15.26
NVO:
20.20
SNX:
0.90
NVO:
1.31
SNX:
0.17
NVO:
1.00
SNX:
1.27
NVO:
15.23
SNX:
$45.06B
NVO:
$303.14B
SNX:
$3.00B
NVO:
$255.65B
SNX:
$1.13B
NVO:
$154.08B
Returns By Period
In the year-to-date period, SNX achieves a 4.23% return, which is significantly higher than NVO's -15.54% return. Over the past 10 years, SNX has outperformed NVO with an annualized return of 12.58%, while NVO has yielded a comparatively lower 11.78% annualized return.
SNX
4.23%
8.49%
2.73%
-5.93%
6.84%
19.21%
12.58%
NVO
-15.54%
8.99%
-31.97%
-46.09%
10.66%
18.68%
11.78%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNX vs. NVO — Risk-Adjusted Performance Rank
SNX
NVO
SNX vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TD SYNNEX Corporation (SNX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SNX vs. NVO - Dividend Comparison
SNX's dividend yield for the trailing twelve months is around 1.38%, less than NVO's 2.25% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNX TD SYNNEX Corporation | 1.38% | 1.36% | 1.30% | 1.27% | 0.70% | 0.25% | 1.16% | 1.73% | 0.77% | 1.03% | 0.64% | 0.16% |
NVO Novo Nordisk A/S | 2.25% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
SNX vs. NVO - Drawdown Comparison
The maximum SNX drawdown since its inception was -67.27%, smaller than the maximum NVO drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for SNX and NVO.
Loading data...
Volatility
SNX vs. NVO - Volatility Comparison
The current volatility for TD SYNNEX Corporation (SNX) is 7.27%, while Novo Nordisk A/S (NVO) has a volatility of 13.11%. This indicates that SNX experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SNX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between TD SYNNEX Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNX vs. NVO - Profitability Comparison
SNX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, TD SYNNEX Corporation reported a gross profit of 998.01M and revenue of 14.53B. Therefore, the gross margin over that period was 6.9%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.
SNX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, TD SYNNEX Corporation reported an operating income of 304.46M and revenue of 14.53B, resulting in an operating margin of 2.1%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.
SNX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, TD SYNNEX Corporation reported a net income of 167.54M and revenue of 14.53B, resulting in a net margin of 1.2%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.